NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

頭頸癌:開發中產品分析

Head And Neck Cancer (Oncology) - Drugs In Development, 2021

出版商 Global Markets Direct 商品編碼 351248
出版日期 內容資訊 英文 4327 Pages
訂單完成後即時交付
價格
頭頸癌:開發中產品分析 Head And Neck Cancer (Oncology) - Drugs In Development, 2021
出版日期: 2021年08月30日內容資訊: 英文 4327 Pages
簡介

頭頸癌是在頭部或頸部(鼻腔,副鼻腔,嘴唇,口,唾液腺,喉嚨或喉)等領域發生的癌症。這個癌症的一般症狀有喉嚨的持續性疼痛,伴隨吞嚥的疼痛和困難,持續性的嘶啞聲和聲音變化,耳朵的疼痛,口內和喉嚨出血等。可用化療和放射治療管理。

本報告提供頭頸癌的治療藥開發平台現狀及最新更新的各開發階段比較分析,提供您企業和研究機關開發中治療藥,治療藥評估,後期階段及中止的計劃等相關資訊。

簡介

頭頸癌概要

治療藥的開發

頭頸癌:治療藥的評估

頭頸癌治療藥的開發企業

藥物簡介

頭頸癌:暫停中的計劃

頭頸癌:開發中止的產品

頭頸癌:產品開發的里程碑

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC13045IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Drugs In Development, 2021, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 23, 257, 225, 4, 8, 172, 42 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 14, 12, 1, 25, 4 and 1 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)

Reasons to Buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

  • Introduction
  • Head And Neck Cancer - Overview
  • Head And Neck Cancer - Therapeutics Development
  • Head And Neck Cancer - Therapeutics Assessment
  • Head And Neck Cancer - Companies Involved in Therapeutics Development
  • Head And Neck Cancer - Drug Profiles
  • Head And Neck Cancer - Dormant Projects
  • Head And Neck Cancer - Discontinued Products
  • Head And Neck Cancer - Product Development Milestones
  • Appendix

List of Tables

List of Tables

  • Number of Products under Development for Head And Neck Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Head And Neck Cancer - Pipeline by 2A Pharma AB, 2021
  • Head And Neck Cancer - Pipeline by 4D Pharma Plc, 2021
  • Head And Neck Cancer - Pipeline by 4SC AG, 2021
  • Head And Neck Cancer - Pipeline by A2 Biotherapeutics Inc, 2021
  • Head And Neck Cancer - Pipeline by Aadi Bioscience Inc, 2021
  • Head And Neck Cancer - Pipeline by ABBA Therapeutics AG, 2021
  • Head And Neck Cancer - Pipeline by AbbVie Inc, 2021
  • Head And Neck Cancer - Pipeline by Abion Inc, 2021
  • Head And Neck Cancer - Pipeline by Accendatech Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Achilles Therapeutics UK Ltd, 2021
  • Head And Neck Cancer - Pipeline by Actuate Therapeutics Inc, 2021
  • Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, 2021
  • Head And Neck Cancer - Pipeline by ADC Therapeutics SA, 2021
  • Head And Neck Cancer - Pipeline by Adlai Nortye Biopharma Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Advanced Accelerator Applications SA, 2021
  • Head And Neck Cancer - Pipeline by Advaxis Inc, 2021
  • Head And Neck Cancer - Pipeline by Advenchen Laboratories LLC, 2021
  • Head And Neck Cancer - Pipeline by Adze Biotechnology Inc, 2021
  • Head And Neck Cancer - Pipeline by Affimed GmbH, 2021
  • Head And Neck Cancer - Pipeline by AGC Biologics SpA, 2021
  • Head And Neck Cancer - Pipeline by Agenus Inc, 2021
  • Head And Neck Cancer - Pipeline by Akeso Inc, 2021
  • Head And Neck Cancer - Pipeline by Alkermes Plc, 2021
  • Head And Neck Cancer - Pipeline by Alligator Bioscience AB, 2021
  • Head And Neck Cancer - Pipeline by Alphageneron-Pharmaceuticals Inc, 2021
  • Head And Neck Cancer - Pipeline by Alphamab Oncology, 2021
  • Head And Neck Cancer - Pipeline by ALX Oncology Holdings Inc, 2021
  • Head And Neck Cancer - Pipeline by Ambrx Biopharma Inc, 2021
  • Head And Neck Cancer - Pipeline by amcure GmbH, 2021
  • Head And Neck Cancer - Pipeline by Amgen Inc, 2021
  • Head And Neck Cancer - Pipeline by AMI Onco Theranostics LLC, 2021
  • Head And Neck Cancer - Pipeline by AnBogen Therapeutics, 2021
  • Head And Neck Cancer - Pipeline by ANP Technologies Inc, 2021
  • Head And Neck Cancer - Pipeline by Anteris Technologies Ltd, 2021
  • Head And Neck Cancer - Pipeline by AP Biosciences Inc, 2021
  • Head And Neck Cancer - Pipeline by Apexigen Inc, 2021
  • Head And Neck Cancer - Pipeline by Apollomics Inc, 2021
  • Head And Neck Cancer - Pipeline by Arch Oncology Inc, 2021
  • Head And Neck Cancer - Pipeline by Arcus Biosciences Inc, 2021
  • Head And Neck Cancer - Pipeline by Immvira Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Imugene Ltd, 2021
  • Head And Neck Cancer - Pipeline by IMV Inc, 2021
  • Head And Neck Cancer - Pipeline by Incyte Corp, 2021
  • Head And Neck Cancer - Pipeline by Infinity Pharmaceuticals Inc, 2021
  • Head And Neck Cancer - Pipeline by Inhibrx Inc, 2021
  • Head And Neck Cancer - Pipeline by Innate Pharma SA, 2021
  • Head And Neck Cancer - Pipeline by InnoMab Pte Ltd, 2021
  • Head And Neck Cancer - Pipeline by Innovene, 2021
  • Head And Neck Cancer - Pipeline by Shanghai Jing Ze Biotechnology Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Shanghai Junshi Bioscience Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Shanghai Miracogen Inc, 2021
  • Head And Neck Cancer - Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Shattuck Labs Inc, 2021
  • Head And Neck Cancer - Pipeline by Shenghe (China) Biopharmaceutical Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Shionogi & Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, 2021
  • Head And Neck Cancer - Pipeline by Silverback Therapeutics Inc, 2021
  • Head And Neck Cancer - Pipeline by Simcha Therapeutics Inc, 2021
  • Head And Neck Cancer - Pipeline by Sino Biopharmaceutical Ltd, 2021
  • Head And Neck Cancer - Pipeline by Sirnaomics Inc, 2021
  • Head And Neck Cancer - Pipeline by Sirona Therapeutics Inc, 2021Head And Neck Cancer - Pipeline by SQZ Biotechnologies

List of Figures

List of Figures

  • Number of Products under Development for Head And Neck Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021